About Us
About Us
Our Stories
Academic Promotion
International Cooperation
Facilities
R&D-Pipeline
R&D
R&D Platform
Nuclear Medicine
Nuclear Medicine
Radioisotope
Radiopharmaceutical
Radiopharmaceuticals Production
News
Company News
Careers
Company Culture
Welfare
Contact Us
中
About Us
R&D-Pipeline
Nuclear Medicine
News
Careers
Contact Us
Company News
Cerveau Technologies Signs Agreement with Janssen for Novel Tau Imaging Agent
…
2017-10-16
View details
Cerveau Technologies Signs Agreement with H. Lundbeck A/S for Novel Tau Imaging Agent
…
2017-09-14
View details
Cerveau Technologies Announces Collaboration with NYU Langone Medical Center
…
2017-06-26
View details
Cerveau Announces FDA Acceptance of Investigational New Drug for Tau Imaging Agent
…
2017-06-16
View details
Cerveau Technologies Collaborates With Singapore's Clinical Imaging Research Centre
…
2017-05-24
View details
Cerveau Technologies Signs Research Agreement with Wisconsin Alzheimer's Research Center
…
2017-03-06
View details
Cerveau Technologies Signs License Agreement with Merck for Novel Tau Imaging Agent
…
2017-01-05
View details
Sinotau Shares Notes on Alzheimer's Disease with Professor Gauthier from MacGill University
…
2016-10-21
View details
Sinotau Signs Agreement for Cardiac Imaging Agents CardioPet and BFPET
…
2016-06-06
View details
Sinotau Obtains Rights in China for the Radiopharmaceutical Diagnostic Agent Lymphoseek®
…
2016-02-01
View details
Sinotau Moves Beijing Headquarters to a New Location within the City: Zhongguancun Life Science Park
…
2016-01-25
View details
Sinotau Submitted 7 ANDA Filings for Foreign Formulations before CFDA in 2015
…
2015-12-30
View details
« 上一页
1
2
